Back to Search
CHRIS RHOADES, M.D.
M.D.
Hematology & Oncology Physician
NPI: 1588672794IndividualAccepts Medicare
Specialties, Licenses & Credentials
Hematology & Oncology PhysicianPrimary
Internal Medicine — Hematology & Oncology
Code: 207RH0003X
35063999(OH)
Education
OHIO STATE UNIVERSITY COLLEGE OF MEDICINE
Class of 1990
Research & Publications (18)
Multimodal intensification regimens for advanced, resectable, previously untreated squamous cell cancer of the oral cavity, oropharynx, or hypopharynx: a 12-year experience.
PMID 17438244·Arch Otolaryngol Head Neck Surg·2007
3-trial
Phase II study of weekly docetaxel and capecitabine in patients with metastatic breast cancer.
PMID 16800973·Clin Breast Cancer·2006
3-trial
Phase II trial of bevacizumab in combination with weekly docetaxel in metastatic breast cancer patients.
PMID 16707611·Clin Cancer Res·2006
3-trial
Assessment of tumor necrosis factor alpha blockade as an intervention to improve tolerability of dose-intensive chemotherapy in cancer patients.
PMID 16622259·J Clin Oncol·2006
2-rct
Intensification regimen for advanced-stage resectable hypopharyngeal carcinoma.
PMID 16618907·Arch Otolaryngol Head Neck Surg·2006
2-rct
Long-term results of a multimodal intensification regimen for previously untreated advanced resectable squamous cell cancer of the oral cavity, oropharynx, or hypopharynx.
PMID 16585867·Laryngoscope·2006
3-trial
Prospective evaluation of the relationship of patient age and paclitaxel clinical pharmacology: Cancer and Leukemia Group B (CALGB 9762).
PMID 16567769·J Clin Oncol·2006
3-trial
Phase II trial of neoadjuvant chemotherapy with docetaxel followed by epirubicin in stage II/III breast cancer.
PMID 16184461·Breast Cancer Res Treat·2005
3-trial
Phase I trial of liposomal encapsulated doxorubicin (Myocet; D-99) and weekly docetaxel in advanced breast cancer patients.
PMID 15849219·Ann Oncol·2005
3-trial
What important step must be considered before transferring a patient from one facility to another?
PMID 15754566·Crit Care Nurse·2005
8-other
Disease control, survival, and functional outcome after multimodal treatment for advanced-stage tongue base cancer.
PMID 15229898·Head Neck·2004
8-other
In vitro cytotoxic effects of stabilizing sugars within human intravenous immunoglobulin preparations against the human macrophage THP-1 cell-line.
PMID 14530170·Hematology·2003
8-other
Multimodal intensification therapy for previously untreated advanced resectable squamous cell carcinoma of the oral cavity, oropharynx, or hypopharynx.
PMID 12115349·Cancer·2002
3-trial
Long-term follow-up on an intensified treatment regimen for advanced resectable head and neck squamous cell carcinomas.
PMID 11296617·Cancer Invest·2001
3-trial
Induction paclitaxel in previously untreated, resectable, advanced squamous cell carcinomas of head and neck.
PMID 11135220·Cancer·2000
3-trial
Monocyte-macrophage system as targets for immunomodulation by intravenous immunoglobulin.
PMID 10805258·Blood Rev·2000
6-review
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 803 W MARKET ST, SUITE 200
LIMA, OH 45805 - Phone
- (419) 222-3737
Quick Facts
- NPI
- 1588672794
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 36
- Publications
- 18
Are you this provider?
Claim Your Profile